Inactive Instrument
Quotes Human Genome Sciences
Stocks
US4449031081
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 27/07/12 | Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources | RE |
| 16/07/12 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
Stock exchange
Nasdaq- $
-
0
$
| Markets | Price | Change | Volumes |
|---|
Basic data
Market Cap (USD)
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 0 | ||
| +0.19% | -3.96% | +54.92% | +69.15% | 65.42B | ||
| -0.14% | -3.20% | +7.62% | +89.74% | 58.91B | ||
| +0.06% | +0.15% | +25.94% | +87.89% | 55.24B | ||
| -0.97% | -3.91% | +12.98% | +113.88% | 45.66B | ||
| -2.83% | -7.58% | +15.21% | +22.34% | 41.29B | ||
| +3.61% | +2.63% | +21.96% | +46.39% | 36.82B | ||
| -0.24% | -9.59% | +126.05% | +647.44% | 34.48B | ||
| +0.03% | -0.93% | +76.71% | +57.74% | 32.5B | ||
| +20.58% | +22.35% | -29.03% | +482.03% | 31.69B | ||
| Average | +2.25% | -0.39% | +34.71% | +179.62% | 40B | |
| Weighted average by Cap. | +1.55% | -0.98% | +33.39% | +154.16% |
Historical Quotes: Human Genome Sciences
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- Stock
- Quotes Human Genome Sciences
Select your edition
All financial news and data tailored to specific country editions
















